ultracaresupport.com
Rare Disease Patient Services & Treatment Suite | UltraCareUltraCare by Ultragenyx connects people living with rare diseases to support resources and financial assistance programs needed to manage their treatment journey.
Known alternatives and similar websites from available relationship data, with available traffic and value estimates.
Website title: MEPSEVII™ (vestronidase alfa-vjbk) is the first and only enzyme replacement therapy for MPS VII
Competitor lists are based on existing similarity relationships. A similar website is not necessarily a direct business competitor.
Missing figures are shown as unavailable, not as zero.
Swipe the table to compare metrics. Website names stay visible while you scroll.
| Website | Estimated worth | Monthly visits (est.) | Monthly pageviews (est.) | Report |
|---|---|---|---|---|
Uultracaresupport.com
Rare Disease Patient Services & Treatment Suite | UltraCare | $867 | 967 | 1.5K | |
Uultragenyx.com
Ultragenyx—Treatment of Rare and Ultrarare Genetic Diseases | $14.1K | 30.5K | 48.8K |
UltraCare by Ultragenyx connects people living with rare diseases to support resources and financial assistance programs needed to manage their treatment journey.
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Similar-site relationships are taken from the legacy Siteprice dataset where available. The estimated value, visits and pageviews shown alongside those sites are drawn from the current Website estimates when a matching domain record exists.
The presence of a competitor is not a verified business relationship, and the absence of a figure doesn't mean the website has no traffic or value.